Evidence map›Paper›PMID 38161496›Full record

ArticleJournal of clinical and translational hepatology2023

Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).

Han Wang, Jun Chen, Xin Zhang, Xia Sheng, Xiao-Yan Chang, Jie Chen, Min-Shan Chen, Hui Dong, Guang-Jie Duan, He-Ping Hu and 38 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. ATP-binding Cassette Transporter Defects and Their Roles in Hepatic Diseases.Journal of clinical and translational hepatology · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Han WangDepartment of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Jun ChenDepartment of Pathology, the Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China.
Xin ZhangDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xia ShengDepartment of Pathology, Minhang Hospital, Fudan University, Shanghai, China.
Xiao-Yan ChangDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jie ChenDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Min-Shan ChenDepartment of Liver Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
Hui DongDepartment of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Guang-Jie DuanDepartment of Pathology, The First Affiliated Hospital, Army Medical University, Chongqing, China.
He-Ping HuDepartment of Hepatobiliary Medicine, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Zhi-Yong HuangHepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Wei-Dong JiaDepartment of General Surgery, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Xiao-Qing JiangDepartment of Biliary Surgery I, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Dong KuangDepartment of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Shan-Shan LiDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Zeng-Shan LiDepartment of Pathology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Chang-Li LuDepartment of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Shu-Kui QinCancer Center of Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Xue-Shan QiuDepartment of Pathology, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China.
Li-Juan QuDepartment of Pathology, The 900 Hospital of the Chinese People's Liberation Army Joint Logistics Team, Fuzhou, Fujian, China.
Chun-Kui ShaoDepartment of Pathology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Feng ShenDepartment of Hepatic Surgery IV, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Guo-Ming ShiDepartment of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
Su-Sheng ShiDepartment of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Yu-Jun ShiInstitute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Hui-Chuan SunDepartment of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiao-Dong TengDepartment of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Bin WangDepartment of Pathology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Zhan-Bo WangDepartment of Pathology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Tian-Fu WenDepartment of Liver Surgery & Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Jia-Mei YangDepartment of Special Medical Care, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Qiao-Qiao YangDepartment of Neurosurgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Sheng-Long YeLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Hong-Fang YinDepartment of Pathology, Beijing Tsinghua Changgung Hospital, Beijing, China.
Zhen-Gang YuanDepartment of Oncology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Jing-Ping YunDepartment of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
Feng-Lin ZangDepartment of Pathology, Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.
Hong-Qi ZhangDepartment of Anatomy, Histology and Embryology, Shanghai Medical College, Fudan University, Shanghai, China.
Li-Hong ZhangDepartment of Anatomy, Histology and Embryology, Shanghai Medical College, Fudan University, Shanghai, China.
Jing-Min ZhaoDepartment of Pathology and Hepatology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
Jian ZhouDepartment of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
Wei-Xun ZhouDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jia FanDepartment of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiao-Ping ChenHepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Wan Yee LauFaculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.
Yuan JiDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-2631-9082
Wen-Ming CongDepartment of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.ORCID https://orcid.org/0000-0002-8924-5551
Chinese Society of Liver Cancer of Chinese Anti-Cancer Association; Digestive Disease Group of Chinese Society of Pathology, Chinese Medical Association; Chinese Society of Pathology of Chinese Anti-Cancer Association; Hepatic Surgery Group of Chinese Society of Surgery, Chinese Medical Association; Biliary Tract Tumor Committee of China Anti-Cancer Association; Chinese Society of Clinical Oncology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrahepatic cholangiocarcinoma (iCCA) can originate from the large bile duct group (segment bile ducts and area bile ducts), small bile duct group (septal bile ducts and interlobular bile ducts), and terminal bile duct group (bile ductules and canals of Hering) of the intrahepatic biliary tree, which can be histopathological corresponding to large duct type iCCA, small duct type iCCA and iCCA with ductal plate malformation pattern, and cholangiolocarcinoma, respectively. The challenge in pathological diagnosis of above subtypes of iCCA falls in the distinction of cellular morphologies, tissue structures, growth patterns, invasive behaviors, immunophenotypes, molecular mutations, and surgical prognoses. For these reasons, this expert consensus provides nine recommendations as a reference for standardizing and refining the diagnosis of pathological subtypes of iCCA, mainly based on the 5

Indexed as

Histological typeImmunohistochemistryIntrahepatic cholangiocarcinomaMolecular variationPathology

Identifiers

PMID38161496
PMCPMC10752808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.